Device Trial Radar · NCT05142800
Screening For BCRL In Targeted Therapy For Breast Cancer
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
261
Planned (sponsor's estimate)
Start
Dec 13, 2018
Primary completion
Sep 30, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Massachusetts General HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Heinz Family Foundation
- First posted
- Dec 3, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer. A Perometer and Sozo devise will be used to measure volume changes
Conditions
- Lymphedema
- Lymphedema Arm
- Lymphedema of Upper Arm
- Lymphedema of Upper Limb
- Lymphedema of the Hands
- Edema
- Edema Arm
- Breast Cancer Lymphedema
- Breast Cancer Metastatic
- Breast Cancer Stage
- Breast Cancer
Interventions
PerometerDevice
The perometer uses light sensors to calculate the length and volume of your arms
SOZO deviceDevice
The machine measures the amount of fluid on the arm(s)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with a greater than or equal to 10% arm volume change from the first pre-treatment (targeted therapy) measurement, detected by perometry, occurring at least three months after breast surgeryTime frame: At least three months post surgery up to 5 years, assessed every 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.